Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy

Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy

In recent years, immunotherapy has become the most promising therapy for a variety of cancer types. The development of immune checkpoint blockade (ICB) therapies, the adoptive transfer of tumor-specific T cells (adoptive cell therapy (ACT)) or the generation of T cells engineered with chimeric antig...

Full description

Bibliographic Details
Main Authors: Pierpaolo Ginefra, Girieca Lorusso, Nicola Vannini
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
immunotolerance
immunotherapy
innate immunity
adaptive immunity
myeloid cells
Online Access:https://www.mdpi.com/1422-0067/21/12/4441

Similar Items

Similar Items